Clinical Trial Update: Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

ClinicalTrials.gov reports the completion of a Phase 3 trial evaluating low-dose theophylline as an anti-inflammatory enhancer for severe chronic obstructive pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Hospital Son Espases | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED